| Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices—Enhanced stability and release H Valo, M Kovalainen, P Laaksonen, M Häkkinen, S Auriola, L Peltonen, ... Journal of controlled release 156 (3), 390-397, 2011 | 121 | 2011 |
| In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ... Journal of Controlled Release 137 (2), 166-170, 2009 | 121 | 2009 |
| Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation E Tauriainen, M Luostarinen, E Martonen, P Finckenberg, M Kovalainen, ... Journal of nutrition and metabolism 2011, 2011 | 85 | 2011 |
| Mesoporous silicon (PSi) for sustained peptide delivery: effect of PSi microparticle surface chemistry on peptide YY3-36 release M Kovalainen, J Mönkäre, E Mäkilä, J Salonen, VP Lehto, KH Herzig, ... Pharmaceutical research 29 (3), 837-846, 2012 | 78 | 2012 |
| Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations M Kaasalainen, E Mäkilä, J Riikonen, M Kovalainen, K Järvinen, ... International journal of pharmaceutics 431 (1-2), 230-236, 2012 | 76 | 2012 |
| Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery M Kilpeläinen, J Mönkäre, MA Vlasova, J Riikonen, VP Lehto, J Salonen, ... European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 20-25, 2011 | 73 | 2011 |
| Nanocrystal-based per-oral itraconazole delivery: Superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption A Sarnes, M Kovalainen, MR Häkkinen, T Laaksonen, J Laru, J Kiesvaara, ... Journal of Controlled release 180, 109-116, 2014 | 61 | 2014 |
| Development of porous silicon nanocarriers for parenteral peptide delivery M Kovalainen, J Monkare, M Kaasalainen, J Riikonen, VP Lehto, ... Molecular pharmaceutics 10 (1), 353-359, 2013 | 51 | 2013 |
| Novel delivery systems for improving the clinical use of peptides M Kovalainen, J Mönkäre, J Riikonen, U Pesonen, M Vlasova, J Salonen, ... Pharmacological reviews 67 (3), 541-561, 2015 | 50 | 2015 |
| The effects of group and single housing and automated animal monitoring on urinary corticosterone levels in male C57 BL/6 mice R Kamakura, M Kovalainen, J Leppäluoto, KH Herzig, KA Mäkelä Physiological reports 4 (3), e12703, 2016 | 43 | 2016 |
| Fat mass-and obesity-associated gene Fto affects the dietary response in mouse white adipose tissue J Ronkainen, TJ Huusko, R Soininen, E Mondini, F Cinti, KA Mäkelä, ... Scientific reports 5, 9233, 2015 | 41 | 2015 |
| Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity A Huotari, W Xu, J Mönkäre, M Kovalainen, KH Herzig, VP Lehto, ... International journal of pharmaceutics 454 (1), 67-73, 2013 | 33 | 2013 |
| Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib J Riikonen, A Correia, M Kovalainen, S Näkki, M Lehtonen, J Leppänen, ... Biomaterials 52, 44-55, 2015 | 29 | 2015 |
| Biocompatible photocrosslinked poly (ester anhydride) based on functionalized poly (ε-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo J Mönkäre, RA Hakala, MA Vlasova, A Huotari, M Kilpeläinen, A Kiviniemi, ... Journal of controlled release 146 (3), 349-355, 2010 | 29 | 2010 |
| Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice LH Vähätalo, ST Ruohonen, S Mäkelä, M Kovalainen, A Huotari, ... Acta physiologica 213 (4), 902-919, 2015 | 28 | 2015 |
| Photocrosslinked poly (ester anhydride) s for peptide delivery: Effect of oligomer hydrophobicity on PYY3-36 delivery J Mönkäre, RA Hakala, M Kovalainen, H Korhonen, KH Herzig, ... European journal of pharmaceutics and biopharmaceutics 80 (1), 33-38, 2012 | 10 | 2012 |
| Nanocarriers and the delivered drug: Effect interference due to intravenous administration MA Vlasova, J Rytkönen, J Riikonen, OS Tarasova, J Mönkäre, ... European Journal of Pharmaceutical Sciences 63, 96-102, 2014 | 8 | 2014 |
| Mesoporous silicon microparticles as carriers for peptides M Kilpeläinen, J Mönkäre, J Riikonen, M Vlasova, J Salonen, VP Lehto, ... Journal of Controlled Release 1 (148), e43-e44, 2010 | 7 | 2010 |
| Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance HB Schultz, M Kovalainen, KF Peressin, N Thomas, CA Prestidge Journal of Pharmacology and Experimental Therapeutics 370 (3), 742-750, 2019 | 5 | 2019 |
| Biodegradation of inorganic drug delivery systems in subcutaneous conditions M Kovalainen, R Kamakura, J Riikonen, M Finnilä, T Nissinen, ... European Journal of Pharmaceutics and Biopharmaceutics 122, 113-125, 2018 | 5 | 2018 |
